BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24763631)

  • 1. Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: a preliminary experience.
    Kim CK; Park SY; Park BK; Park W; Huh SJ
    Eur Radiol; 2014 Jul; 24(7):1514-20. PubMed ID: 24763631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of blood oxygenation level-dependent MRI for predicting clinical outcomes in uterine cervical cancer treated with concurrent chemoradiotherapy.
    Lee J; Kim CK; Gu KW; Park W
    Eur Radiol; 2019 Nov; 29(11):6256-6265. PubMed ID: 31016443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Early Therapeutic Changes to Concurrent Chemoradiotherapy in Uterine Cervical Cancer Using Blood Oxygenation Level-Dependent Magnetic Resonance Imaging.
    Choi SH; Kim CK; Park JJ; Park BK
    J Comput Assist Tomogr; 2016; 40(5):730-4. PubMed ID: 27636125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy?
    Bae JM; Kim CK; Park JJ; Park BK
    Abdom Radiol (NY); 2016 Aug; 41(8):1604-10. PubMed ID: 27056747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
    Park JJ; Kim CK; Park SY; Simonetti AW; Kim E; Park BK; Huh SJ
    Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced 3-T MR imaging in cervical cancer before and after concurrent chemoradiotherapy.
    Kim JH; Kim CK; Park BK; Park SY; Huh SJ; Kim B
    Eur Radiol; 2012 Nov; 22(11):2533-9. PubMed ID: 22653283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment response of patients undergoing concurrent chemoradiotherapy for cervical cancer: An evaluation of integrated multi-parameter PET-IVIM MR.
    Xu C; Sun H; Du S; Xin J
    Eur J Radiol; 2019 Aug; 117():1-8. PubMed ID: 31307633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Treatment Response for Cervical Cancer Treated with Concurrent Chemoradiotherapy.
    Lu H; Wu Y; Liu X; Huang H; Jiang H; Zhu C; Man Y; Liu P; Li X; Chen Z; Long X; Pang Q; Deng S; Gu J
    Cancer Manag Res; 2021; 13():6065-6078. PubMed ID: 34377025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early response of patients undergoing concurrent chemoradiotherapy for cervical cancer: a comparison of PET/CT and MRI.
    Lee JE; Huh SJ; Nam H; Ju SG
    Ann Nucl Med; 2013 Jan; 27(1):37-45. PubMed ID: 23054833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of magnetic resonance blood oxygen level-dependent imaging in evaluating the efficacy of advanced cervical cancer combined with radiotherapy and chemotherapy.
    Yin L; Zhuang X; Li JL
    Acta Radiol; 2023 Apr; 64(4):1668-1675. PubMed ID: 36464651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic values of ADC
    Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
    J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET/CT and MRI in locally advanced cervical cancer.
    Min LA; Ackermans LL; Nowee ME; Griethuysen JJV; Roberti S; Maas M; Vogel WV; Beets-Tan RG; Lambregts DM
    Acta Radiol; 2021 Jul; 62(7):940-948. PubMed ID: 32722967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of R2* obtained from T2*-weighted imaging in predicting the prognosis of advanced cervical squamous carcinoma treated with concurrent chemoradiotherapy.
    Li XS; Fan HX; Fang H; Song YL; Zhou CW
    J Magn Reson Imaging; 2015 Sep; 42(3):681-8. PubMed ID: 25581675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
    Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
    Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
    Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response.
    Banks TI; von Eyben R; Hristov D; Kidd EA
    Cancer Med; 2018 Aug; 7(8):3642-3651. PubMed ID: 29963760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between MRI histogram features and treatment response in locally advanced cervical cancer treated by chemoradiotherapy.
    Perucho JAU; Wang M; Tse KY; Ip PPC; Siu SWK; Ngan HYS; Khong PL; Lee EYP
    Eur Radiol; 2021 Mar; 31(3):1727-1735. PubMed ID: 32885298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors.
    Yang W; Qiang JW; Tian HP; Chen B; Wang AJ; Zhao JG
    Eur Radiol; 2018 Jan; 28(1):437-445. PubMed ID: 28779395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting and Early Monitoring Treatment Efficiency of Cervical Cancer Under Concurrent Chemoradiotherapy by Intravoxel Incoherent Motion Magnetic Resonance Imaging.
    Zhu L; Zhu L; Wang H; Yan J; Liu B; Chen W; He J; Zhou Z; Yang X
    J Comput Assist Tomogr; 2017; 41(3):422-429. PubMed ID: 27824669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.